In the pharmaceutical industry, where the effects of compromised production output can be far-reaching, having efficient and reliable asset performance is essential. For many pharmaceutical companies, reducing asset downtime has proven to be a worthwhile venture, translating to lower maintenance costs, increased efficiency, and a more productive and engaged workforce.
To help improve asset reliability, a leading pharmaceutical manufacturer engaged Nexus Global to conduct a PM Optimization (PMO) Strategy review at one of their facilities. For this particular site, maximizing machine utilization was vital to avoid moving manufacturing to a new facility.
By using PMO methodology and Strategy Optimizer™, Nexus Global was able to successfully develop and implement an optimized PM program in 6 weeks. With the new strategy in place, the site showed a 30% reduction in PM labor/activities with savings in the hundreds of thousands in machine availability. The project proved to be a very valuable initiative for the client with the highest ROI of all projects completed within the company that year.
Download the case study to find out how Nexus Global implemented a culture of reliability over repair to transform a manufacturing site on the brink of shutting down into one of the most reliable and efficient facilities in the pharmaceutical company.
Larry Olson | CMRP, CRL, CAMA
President/CEO, Nexus Global | Larry is one of the leading global Shutdown/Turnaround, Asset Integrity and Maintenance strategists. With over 30+ years of business & maintenance experience, he has carried out a variety of roles from Project Manager, Change Management Specialist to Director of Reliability & Integrity Assurance Excellence.